Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Growth (Status and Outlook) 2026-2032
The global Circulating Tumor Cells (CTC) Liquid Biopsy market size is predicted to grow from US$ 1510 million in 2025 to US$ 3764 million in 2032; it is expected to grow at a CAGR of 14.2% from 2026 to 2032.
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTC) Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTC) Liquid Biopsy sales in 2025, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTC) Liquid Biopsy sales for 2026 through 2032. With Circulating Tumor Cells (CTC) Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTC) Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circulating Tumor Cells (CTC) Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTC) Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTC) Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTC) Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
North America dominates global circulating tumor cells (CTC) liquid biopsy market. This is majorly due to the growing adoption of the liquid biopsy in the North American region for diagnosis of cancer. There are rapidly growing cases of cancer in US which has contributed in the dominance of North America in the global liquid biopsy market.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells (CTC) Liquid Biopsy Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells (CTC) Liquid Biopsy sales in 2025, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells (CTC) Liquid Biopsy sales for 2026 through 2032. With Circulating Tumor Cells (CTC) Liquid Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells (CTC) Liquid Biopsy industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells (CTC) Liquid Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circulating Tumor Cells (CTC) Liquid Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells (CTC) Liquid Biopsy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells (CTC) Liquid Biopsy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells (CTC) Liquid Biopsy.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Kits & Reagents
- Blood Collection Tubes
- Devices
- Research & Academic Institutes
- Hospitals
- Physician Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- Bio-Techne
- Precision Medical
- Aviva Systems Biological
- Biocept
- Fluxion Biosciences
- Greiner Bio-One International GmbH
- Ikonisys
- Miltenyi Biotec
- IVDiagnostics
- BioFluidica
- Canopus Medical
- Biolidics
- Creativ MicroTech
- LungLife AI
- Epic Sciences
- Rarecells Diagnostics
- ScreenCell
- Menarini Silicon Biosystems
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2021-2032)
2.1.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Circulating Tumor Cells (CTC) Liquid Biopsy by Country/Region (2021, 2025 & 2032)
2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
2.2.1 Kits & Reagents
2.2.2 Blood Collection Tubes
2.2.3 Devices
2.2.4 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type
2.2.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
2.3.1 Research & Academic Institutes
2.3.2 Hospitals
2.3.3 Physician Laboratories
2.3.4 Others
2.3.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
2.3.5.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Player
3.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2021-2026)
3.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2021-2026)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY BY REGION
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026)
4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.4 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.6 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026)
5.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
5.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026)
6.2 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
6.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy by Region (2021-2026)
8.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
8.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST
10.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.1.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2027-2032)
10.2.1 United States Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.2 Canada Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.3 Mexico Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.4 Brazil Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.3.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.2 Japan Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.3 Korea Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.4 Southeast Asia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.5 India Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.6 Australia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2027-2032)
10.4.1 Germany Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.2 France Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.3 UK Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.4 Italy Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.5 Russia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.5.1 Egypt Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.2 South Africa Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.3 Israel Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.4 Turkey Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Type (2027-2032)
10.7 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Precision Medical
11.3.1 Precision Medical Company Information
11.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Precision Medical Main Business Overview
11.3.5 Precision Medical Latest Developments
11.4 Aviva Systems Biological
11.4.1 Aviva Systems Biological Company Information
11.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aviva Systems Biological Main Business Overview
11.4.5 Aviva Systems Biological Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Information
11.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fluxion Biosciences Main Business Overview
11.6.5 Fluxion Biosciences Latest Developments
11.7 Greiner Bio-One International GmbH
11.7.1 Greiner Bio-One International GmbH Company Information
11.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Greiner Bio-One International GmbH Main Business Overview
11.7.5 Greiner Bio-One International GmbH Latest Developments
11.8 Ikonisys
11.8.1 Ikonisys Company Information
11.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Ikonisys Main Business Overview
11.8.5 Ikonisys Latest Developments
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Information
11.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Miltenyi Biotec Main Business Overview
11.9.5 Miltenyi Biotec Latest Developments
11.10 IVDiagnostics
11.10.1 IVDiagnostics Company Information
11.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 IVDiagnostics Main Business Overview
11.10.5 IVDiagnostics Latest Developments
11.11 BioFluidica
11.11.1 BioFluidica Company Information
11.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BioFluidica Main Business Overview
11.11.5 BioFluidica Latest Developments
11.12 Canopus Medical
11.12.1 Canopus Medical Company Information
11.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Canopus Medical Main Business Overview
11.12.5 Canopus Medical Latest Developments
11.13 Biolidics
11.13.1 Biolidics Company Information
11.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biolidics Main Business Overview
11.13.5 Biolidics Latest Developments
11.14 Creativ MicroTech
11.14.1 Creativ MicroTech Company Information
11.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Creativ MicroTech Main Business Overview
11.14.5 Creativ MicroTech Latest Developments
11.15 LungLife AI
11.15.1 LungLife AI Company Information
11.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 LungLife AI Main Business Overview
11.15.5 LungLife AI Latest Developments
11.16 Epic Sciences
11.16.1 Epic Sciences Company Information
11.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Epic Sciences Main Business Overview
11.16.5 Epic Sciences Latest Developments
11.17 Rarecells Diagnostics
11.17.1 Rarecells Diagnostics Company Information
11.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Rarecells Diagnostics Main Business Overview
11.17.5 Rarecells Diagnostics Latest Developments
11.18 ScreenCell
11.18.1 ScreenCell Company Information
11.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 ScreenCell Main Business Overview
11.18.5 ScreenCell Latest Developments
11.19 Menarini Silicon Biosystems
11.19.1 Menarini Silicon Biosystems Company Information
11.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Menarini Silicon Biosystems Main Business Overview
11.19.5 Menarini Silicon Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size (2021-2032)
2.1.2 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Circulating Tumor Cells (CTC) Liquid Biopsy by Country/Region (2021, 2025 & 2032)
2.2 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Type
2.2.1 Kits & Reagents
2.2.2 Blood Collection Tubes
2.2.3 Devices
2.2.4 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type
2.2.4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
2.3 Circulating Tumor Cells (CTC) Liquid Biopsy Segment by Application
2.3.1 Research & Academic Institutes
2.3.2 Hospitals
2.3.3 Physician Laboratories
2.3.4 Others
2.3.5 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application
2.3.5.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
3 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Player
3.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2021-2026)
3.1.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2021-2026)
3.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY BY REGION
4.1 Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026)
4.2 Global Circulating Tumor Cells (CTC) Liquid Biopsy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.4 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.5 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
4.6 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026)
5.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
5.3 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026)
6.2 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
6.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026)
7.2 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
7.3 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy by Region (2021-2026)
8.2 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026)
8.3 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS (CTC) LIQUID BIOPSY MARKET FORECAST
10.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.1.1 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.1.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2 Americas Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2027-2032)
10.2.1 United States Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.2 Canada Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.3 Mexico Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.2.4 Brazil Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3 APAC Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.3.1 China Circulating Tumor Cells (CTC) Liquid Biopsy Market Forecast
10.3.2 Japan Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.3 Korea Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.4 Southeast Asia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.5 India Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.3.6 Australia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4 Europe Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Country (2027-2032)
10.4.1 Germany Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.2 France Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.3 UK Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.4 Italy Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.4.5 Russia Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5 Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Region (2027-2032)
10.5.1 Egypt Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.2 South Africa Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.3 Israel Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.5.4 Turkey Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
10.6 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Type (2027-2032)
10.7 Global Circulating Tumor Cells (CTC) Liquid Biopsy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Circulating Tumor Cells (CTC) Liquid Biopsy Forecast
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.1.3 QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.2.3 Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Precision Medical
11.3.1 Precision Medical Company Information
11.3.2 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.3.3 Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Precision Medical Main Business Overview
11.3.5 Precision Medical Latest Developments
11.4 Aviva Systems Biological
11.4.1 Aviva Systems Biological Company Information
11.4.2 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.4.3 Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aviva Systems Biological Main Business Overview
11.4.5 Aviva Systems Biological Latest Developments
11.5 Biocept
11.5.1 Biocept Company Information
11.5.2 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.5.3 Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Biocept Main Business Overview
11.5.5 Biocept Latest Developments
11.6 Fluxion Biosciences
11.6.1 Fluxion Biosciences Company Information
11.6.2 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.6.3 Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fluxion Biosciences Main Business Overview
11.6.5 Fluxion Biosciences Latest Developments
11.7 Greiner Bio-One International GmbH
11.7.1 Greiner Bio-One International GmbH Company Information
11.7.2 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.7.3 Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Greiner Bio-One International GmbH Main Business Overview
11.7.5 Greiner Bio-One International GmbH Latest Developments
11.8 Ikonisys
11.8.1 Ikonisys Company Information
11.8.2 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.8.3 Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Ikonisys Main Business Overview
11.8.5 Ikonisys Latest Developments
11.9 Miltenyi Biotec
11.9.1 Miltenyi Biotec Company Information
11.9.2 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.9.3 Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Miltenyi Biotec Main Business Overview
11.9.5 Miltenyi Biotec Latest Developments
11.10 IVDiagnostics
11.10.1 IVDiagnostics Company Information
11.10.2 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.10.3 IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 IVDiagnostics Main Business Overview
11.10.5 IVDiagnostics Latest Developments
11.11 BioFluidica
11.11.1 BioFluidica Company Information
11.11.2 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.11.3 BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BioFluidica Main Business Overview
11.11.5 BioFluidica Latest Developments
11.12 Canopus Medical
11.12.1 Canopus Medical Company Information
11.12.2 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.12.3 Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Canopus Medical Main Business Overview
11.12.5 Canopus Medical Latest Developments
11.13 Biolidics
11.13.1 Biolidics Company Information
11.13.2 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.13.3 Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biolidics Main Business Overview
11.13.5 Biolidics Latest Developments
11.14 Creativ MicroTech
11.14.1 Creativ MicroTech Company Information
11.14.2 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.14.3 Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Creativ MicroTech Main Business Overview
11.14.5 Creativ MicroTech Latest Developments
11.15 LungLife AI
11.15.1 LungLife AI Company Information
11.15.2 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.15.3 LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 LungLife AI Main Business Overview
11.15.5 LungLife AI Latest Developments
11.16 Epic Sciences
11.16.1 Epic Sciences Company Information
11.16.2 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.16.3 Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Epic Sciences Main Business Overview
11.16.5 Epic Sciences Latest Developments
11.17 Rarecells Diagnostics
11.17.1 Rarecells Diagnostics Company Information
11.17.2 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.17.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Rarecells Diagnostics Main Business Overview
11.17.5 Rarecells Diagnostics Latest Developments
11.18 ScreenCell
11.18.1 ScreenCell Company Information
11.18.2 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.18.3 ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 ScreenCell Main Business Overview
11.18.5 ScreenCell Latest Developments
11.19 Menarini Silicon Biosystems
11.19.1 Menarini Silicon Biosystems Company Information
11.19.2 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
11.19.3 Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Menarini Silicon Biosystems Main Business Overview
11.19.5 Menarini Silicon Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Circulating Tumor Cells (CTC) Liquid Biopsy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kits & Reagents
Table 4. Major Players of Blood Collection Tubes
Table 5. Major Players of Devices
Table 6. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 9. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2021-2026)
Table 14. Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
Table 15. Circulating Tumor Cells (CTC) Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 24. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 26. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 28. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 34. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 40. Key Market Challenges & Risks of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 41. Key Industry Trends of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 42. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. QIAGEN Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 47. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 48. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. QIAGEN Main Business
Table 50. QIAGEN Latest Developments
Table 51. Bio-Techne Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 52. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 53. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bio-Techne Main Business
Table 55. Bio-Techne Latest Developments
Table 56. Precision Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 57. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 58. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Precision Medical Main Business
Table 60. Precision Medical Latest Developments
Table 61. Aviva Systems Biological Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 62. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 63. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Aviva Systems Biological Main Business
Table 65. Aviva Systems Biological Latest Developments
Table 66. Biocept Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 67. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 68. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Biocept Main Business
Table 70. Biocept Latest Developments
Table 71. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 72. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 73. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fluxion Biosciences Main Business
Table 75. Fluxion Biosciences Latest Developments
Table 76. Greiner Bio-One International GmbH Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 77. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 78. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Greiner Bio-One International GmbH Main Business
Table 80. Greiner Bio-One International GmbH Latest Developments
Table 81. Ikonisys Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 82. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 83. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Ikonisys Main Business
Table 85. Ikonisys Latest Developments
Table 86. Miltenyi Biotec Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 87. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 88. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Miltenyi Biotec Main Business
Table 90. Miltenyi Biotec Latest Developments
Table 91. IVDiagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 92. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 93. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. IVDiagnostics Main Business
Table 95. IVDiagnostics Latest Developments
Table 96. BioFluidica Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 97. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 98. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. BioFluidica Main Business
Table 100. BioFluidica Latest Developments
Table 101. Canopus Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 102. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 103. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Canopus Medical Main Business
Table 105. Canopus Medical Latest Developments
Table 106. Biolidics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 107. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 108. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Biolidics Main Business
Table 110. Biolidics Latest Developments
Table 111. Creativ MicroTech Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 112. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 113. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Creativ MicroTech Main Business
Table 115. Creativ MicroTech Latest Developments
Table 116. LungLife AI Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 117. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 118. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. LungLife AI Main Business
Table 120. LungLife AI Latest Developments
Table 121. Epic Sciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 122. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 123. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Epic Sciences Main Business
Table 125. Epic Sciences Latest Developments
Table 126. Rarecells Diagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 127. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 128. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Rarecells Diagnostics Main Business
Table 130. Rarecells Diagnostics Latest Developments
Table 131. ScreenCell Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 132. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 133. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. ScreenCell Main Business
Table 135. ScreenCell Latest Developments
Table 136. Menarini Silicon Biosystems Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 137. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 138. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Menarini Silicon Biosystems Main Business
Table 140. Menarini Silicon Biosystems Latest Developments
Table 1. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Circulating Tumor Cells (CTC) Liquid Biopsy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kits & Reagents
Table 4. Major Players of Blood Collection Tubes
Table 5. Major Players of Devices
Table 6. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 9. Circulating Tumor Cells (CTC) Liquid Biopsy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 12. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player (2021-2026)
Table 14. Circulating Tumor Cells (CTC) Liquid Biopsy Key Players Head office and Products Offered
Table 15. Circulating Tumor Cells (CTC) Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 24. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Table 26. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Table 28. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Table 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country (2021-2026)
Table 34. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 40. Key Market Challenges & Risks of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 41. Key Industry Trends of Circulating Tumor Cells (CTC) Liquid Biopsy
Table 42. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. QIAGEN Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 47. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 48. QIAGEN Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. QIAGEN Main Business
Table 50. QIAGEN Latest Developments
Table 51. Bio-Techne Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 52. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 53. Bio-Techne Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bio-Techne Main Business
Table 55. Bio-Techne Latest Developments
Table 56. Precision Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 57. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 58. Precision Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Precision Medical Main Business
Table 60. Precision Medical Latest Developments
Table 61. Aviva Systems Biological Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 62. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 63. Aviva Systems Biological Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Aviva Systems Biological Main Business
Table 65. Aviva Systems Biological Latest Developments
Table 66. Biocept Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 67. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 68. Biocept Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Biocept Main Business
Table 70. Biocept Latest Developments
Table 71. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 72. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 73. Fluxion Biosciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fluxion Biosciences Main Business
Table 75. Fluxion Biosciences Latest Developments
Table 76. Greiner Bio-One International GmbH Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 77. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 78. Greiner Bio-One International GmbH Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Greiner Bio-One International GmbH Main Business
Table 80. Greiner Bio-One International GmbH Latest Developments
Table 81. Ikonisys Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 82. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 83. Ikonisys Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Ikonisys Main Business
Table 85. Ikonisys Latest Developments
Table 86. Miltenyi Biotec Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 87. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 88. Miltenyi Biotec Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Miltenyi Biotec Main Business
Table 90. Miltenyi Biotec Latest Developments
Table 91. IVDiagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 92. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 93. IVDiagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. IVDiagnostics Main Business
Table 95. IVDiagnostics Latest Developments
Table 96. BioFluidica Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 97. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 98. BioFluidica Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. BioFluidica Main Business
Table 100. BioFluidica Latest Developments
Table 101. Canopus Medical Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 102. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 103. Canopus Medical Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Canopus Medical Main Business
Table 105. Canopus Medical Latest Developments
Table 106. Biolidics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 107. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 108. Biolidics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Biolidics Main Business
Table 110. Biolidics Latest Developments
Table 111. Creativ MicroTech Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 112. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 113. Creativ MicroTech Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Creativ MicroTech Main Business
Table 115. Creativ MicroTech Latest Developments
Table 116. LungLife AI Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 117. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 118. LungLife AI Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. LungLife AI Main Business
Table 120. LungLife AI Latest Developments
Table 121. Epic Sciences Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 122. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 123. Epic Sciences Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Epic Sciences Main Business
Table 125. Epic Sciences Latest Developments
Table 126. Rarecells Diagnostics Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 127. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 128. Rarecells Diagnostics Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Rarecells Diagnostics Main Business
Table 130. Rarecells Diagnostics Latest Developments
Table 131. ScreenCell Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 132. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 133. ScreenCell Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. ScreenCell Main Business
Table 135. ScreenCell Latest Developments
Table 136. Menarini Silicon Biosystems Details, Company Type, Circulating Tumor Cells (CTC) Liquid Biopsy Area Served and Its Competitors
Table 137. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Product Offered
Table 138. Menarini Silicon Biosystems Circulating Tumor Cells (CTC) Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Menarini Silicon Biosystems Main Business
Table 140. Menarini Silicon Biosystems Latest Developments
LIST OF FIGURES
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2025)
Figure 8. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2025
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy in Research & Academic Institutes
Figure 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Research & Academic Institutes (2021-2026) & ($ millions)
Figure 12. Circulating Tumor Cells (CTC) Liquid Biopsy in Hospitals
Figure 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Circulating Tumor Cells (CTC) Liquid Biopsy in Physician Laboratories
Figure 15. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Physician Laboratories (2021-2026) & ($ millions)
Figure 16. Circulating Tumor Cells (CTC) Liquid Biopsy in Others
Figure 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Others (2021-2026) & ($ millions)
Figure 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2025
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player in 2025
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 22. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 23. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Value Market Share by Country in 2025
Figure 26. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region in 2025
Figure 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 33. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country in 2025
Figure 40. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 56. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 57. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 59. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 60. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 63. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 64. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 65. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 67. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 68. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 69. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 70. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 71. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 72. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 73. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 76. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 78. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 1. Circulating Tumor Cells (CTC) Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Circulating Tumor Cells (CTC) Liquid Biopsy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2025)
Figure 8. Circulating Tumor Cells (CTC) Liquid Biopsy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type in 2025
Figure 10. Circulating Tumor Cells (CTC) Liquid Biopsy in Research & Academic Institutes
Figure 11. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Research & Academic Institutes (2021-2026) & ($ millions)
Figure 12. Circulating Tumor Cells (CTC) Liquid Biopsy in Hospitals
Figure 13. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Circulating Tumor Cells (CTC) Liquid Biopsy in Physician Laboratories
Figure 15. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Physician Laboratories (2021-2026) & ($ millions)
Figure 16. Circulating Tumor Cells (CTC) Liquid Biopsy in Others
Figure 17. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market: Others (2021-2026) & ($ millions)
Figure 18. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application in 2025
Figure 19. Global Circulating Tumor Cells (CTC) Liquid Biopsy Revenue Market Share by Player in 2025
Figure 20. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 22. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 23. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2021-2026 ($ millions)
Figure 25. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Value Market Share by Country in 2025
Figure 26. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region in 2025
Figure 31. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 33. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Country in 2025
Figure 40. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 56. APAC Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 57. Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 59. United States Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 60. Canada Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 63. China Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 64. Japan Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 65. Korea Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 67. India Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 68. Australia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 69. Germany Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 70. France Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 71. UK Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 72. Italy Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 73. Russia Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 76. Israel Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
Figure 78. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Circulating Tumor Cells (CTC) Liquid Biopsy Market Size 2027-2032 ($ millions)
